Global and United States Secondary Progressive Multiple Sclerosis Drug Market 2018 - Research Report, Demand, Price, By Application, Region and Forecast to 2025

 Published Date : Aug-2018   |    Format :PDF |    Number of Pages : 123   |    Publisher : e-Market Research

Summary

This report studies the Secondary Progressive Multiple Sclerosis Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Secondary Progressive Multiple Sclerosis Drug market by product type and application/end industries.

The global Secondary Progressive Multiple Sclerosis Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Secondary Progressive Multiple Sclerosis Drug.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Secondary Progressive Multiple Sclerosis Drug in these regions, from 2013 to 2025 (forecast), covering
    United States
    North America
    Europe
    Asia-Pacific
    South America
    Middle East and Africa

The major players in global and United States market, including
    AB Science SA
    Actelion Ltd
    Biogen, Inc.
    F. Hoffmann-La Roche Ltd.
    Genzyme Corporation
    Glialogix, Inc.
    Immune Response BioPharma, Inc.
    Innate Immunotherapeutics Ltd
    Kyorin Pharmaceutical Co., Ltd.
    Mallinckrodt Plc
    MedDay SA
    MedImmune, LLC
    Merck KGaA
    Meta-IQ ApS
    Novartis AG
    Opexa Therapeutics, Inc.
    Xenetic Biosciences (UK) Limited
On the basis of product, the market is primarily split into
    Inebilizumab
    GLX-1112
    DC-TAB
    Etomoxir
    IB-MS
    Others
On the basis on the end users/application, this report covers
    Hospital
    Clinic
    Others

2018-2025 Secondary Progressive Multiple Sclerosis Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

2 Secondary Progressive Multiple Sclerosis Drug Market Overview
    2.1 Secondary Progressive Multiple Sclerosis Drug Product Overview
    2.2 Secondary Progressive Multiple Sclerosis Drug Market Segment by Type
        2.2.1 Inebilizumab
        2.2.2 GLX-1112
        2.2.3 DC-TAB
        2.2.4 Etomoxir
        2.2.5 IB-MS
        2.2.6 Others
    2.3 Global Secondary Progressive Multiple Sclerosis Drug Product Segment by Type
        2.3.1 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
        2.3.2 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
        2.3.3 Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
        2.3.4 Global Secondary Progressive Multiple Sclerosis Drug Price (USD/Pcs) by Type (2013-2018)
    2.4 United States Secondary Progressive Multiple Sclerosis Drug Product Segment by Type
        2.4.1 United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
        2.4.2 United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Market Share by Type (2013-2018)
        2.4.3 United States Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
        2.4.4 United States Secondary Progressive Multiple Sclerosis Drug Price (USD/Pcs) by Type (2013-2018)

3 Secondary Progressive Multiple Sclerosis Drug Application/End Users
    3.1 Secondary Progressive Multiple Sclerosis Drug Segment by Application/End Users
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Others
    3.2 Global Secondary Progressive Multiple Sclerosis Drug Product Segment by Application
        3.2.1 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        3.2.2 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
    3.3 United States Secondary Progressive Multiple Sclerosis Drug Product Segment by Application
        3.3.1 United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        3.3.2 United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 Secondary Progressive Multiple Sclerosis Drug Market Status and Outlook by Regions
    4.1 Global Market Status and Outlook by Regions
        4.1.1 Global Secondary Progressive Multiple Sclerosis Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
        4.1.2 North America
        4.1.3 Asia-Pacific
        4.1.4 Europe
        4.1.5 South America
        4.1.6 Middle East and Africa
        4.1.7 United States
    4.2 Global Secondary Progressive Multiple Sclerosis Drug Sales and Revenue by Regions
        4.2.1 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
        4.2.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
        4.2.3 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.4 North America Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.5 Europe Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.6 Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.7 South America Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
        4.2.8 Middle East and Africa Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.9 United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 Global Secondary Progressive Multiple Sclerosis Drug Market Competition by Players/Manufacturers
    5.1 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Market Share by Players (2013-2018)
    5.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Share by Players (2013-2018)
    5.3 Global Secondary Progressive Multiple Sclerosis Drug Average Price (USD/Pcs) by Players (2013-2018)
    5.4 Global Top Players Secondary Progressive Multiple Sclerosis Drug Manufacturing Base Distribution, Sales Area, Product Types
    5.5 Secondary Progressive Multiple Sclerosis Drug Market Competitive Situation and Trends
        5.5.1 Secondary Progressive Multiple Sclerosis Drug Market Concentration Rate
        5.5.2 Global Secondary Progressive Multiple Sclerosis Drug Market Share (%) of Top 3 and Top 5 Players
        5.5.3 Mergers & Acquisitions, Expansion

6 United States Secondary Progressive Multiple Sclerosis Drug Market Competition by Players/Manufacturers
    6.1 United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Market Share by Players (2013-2018)
    6.2 United States Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Share by Players (2013-2018)
    6.3 United States Secondary Progressive Multiple Sclerosis Drug Average Price (USD/Pcs) by Players (2013-2018)
    6.4 United States Secondary Progressive Multiple Sclerosis Drug Market Share (%) of Top 3 and Top 5 Players


7 Secondary Progressive Multiple Sclerosis Drug Players/Manufacturers Profiles and Sales Data
    7.1 AB Science SA
        7.1.1 Company Basic Information, Manufacturing Base and Competitors
        7.1.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 AB Science SA Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.1.4 Main Business/Business Overview
    7.2 Actelion Ltd
        7.2.1 Company Basic Information, Manufacturing Base and Competitors
        7.2.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.2.4 Main Business/Business Overview
    7.3 Biogen, Inc.
        7.3.1 Company Basic Information, Manufacturing Base and Competitors
        7.3.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.3.4 Main Business/Business Overview
    7.4 F. Hoffmann-La Roche Ltd.
        7.4.1 Company Basic Information, Manufacturing Base and Competitors
        7.4.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 F. Hoffmann-La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.4.4 Main Business/Business Overview
    7.5 Genzyme Corporation
        7.5.1 Company Basic Information, Manufacturing Base and Competitors
        7.5.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Genzyme Corporation Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.5.4 Main Business/Business Overview
    7.6 Glialogix, Inc.
        7.6.1 Company Basic Information, Manufacturing Base and Competitors
        7.6.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Glialogix, Inc. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.6.4 Main Business/Business Overview
    7.7 Immune Response BioPharma, Inc.
        7.7.1 Company Basic Information, Manufacturing Base and Competitors
        7.7.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Immune Response BioPharma, Inc. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.7.4 Main Business/Business Overview
    7.8 Innate Immunotherapeutics Ltd
        7.8.1 Company Basic Information, Manufacturing Base and Competitors
        7.8.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Innate Immunotherapeutics Ltd Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.8.4 Main Business/Business Overview
    7.9 Kyorin Pharmaceutical Co., Ltd.
        7.9.1 Company Basic Information, Manufacturing Base and Competitors
        7.9.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Kyorin Pharmaceutical Co., Ltd. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.9.4 Main Business/Business Overview
    7.10 Mallinckrodt Plc
        7.10.1 Company Basic Information, Manufacturing Base and Competitors
        7.10.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Mallinckrodt Plc Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.10.4 Main Business/Business Overview
    7.11 MedDay SA
    7.12 MedImmune, LLC
    7.13 Merck KGaA
    7.14 Meta-IQ ApS
    7.15 Novartis AG
    7.16 Opexa Therapeutics, Inc.
    7.17 Xenetic Biosciences (UK) Limited

8 Secondary Progressive Multiple Sclerosis Drug Manufacturing Cost, Industrial Chain and Downstream Buyers
    8.1 Secondary Progressive Multiple Sclerosis Drug Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Price Trend of Key Raw Materials
        8.1.3 Key Suppliers of Raw Materials
        8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
    8.3 Secondary Progressive Multiple Sclerosis Drug Industrial Chain Analysis
    8.4 Downstream Buyers in United States

9 Marketing Strategy Analysis, Distributors and Market Effect Factors
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Distributors in Untied States
    9.3 Market Effect Factors Analysis
        9.3.1 Economic/Political Environmental Change
        9.3.2 Downstream Demand Change
        9.3.3 Technology Progress in Related Industry
        9.3.4 Substitutes Threat

10 Global Secondary Progressive Multiple Sclerosis Drug Market Forecast
    10.1 Global Secondary Progressive Multiple Sclerosis Drug Sales, Revenue Forecast (2018-2025)
        10.1.1 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        10.1.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    10.2 United States Secondary Progressive Multiple Sclerosis Drug Market Forecast
        10.2.1 United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        10.2.2 United States Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    10.3 Global Secondary Progressive Multiple Sclerosis Drug Forecast by Regions
        10.3.1 North America Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.2 Europe Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.3 Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.4 South America Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.5 Middle East and Africa Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
    10.4 Secondary Progressive Multiple Sclerosis Drug Forecast by Type
        10.4.1 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
        10.4.2 United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
    10.5 Secondary Progressive Multiple Sclerosis Drug Forecast by Application
        10.5.1 Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) Forecast by Application (2018-2025)
        10.5.2 United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) Forecast by Application (2018-2025)

11 Research Findings and Conclusion



List of Tables and Figures

    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
    Figure Secondary Progressive Multiple Sclerosis Drug Product Picture
    Figure Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) Status and Outlook (2013-2025)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) Status and Outlook (2013-2025)
    Figure Product Picture of Inebilizumab
    Table Major Players of Inebilizumab
    Figure Global Inebilizumab Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of GLX-1112
    Table Major Players of GLX-1112
    Figure Global GLX-1112 Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of DC-TAB
    Table Major Players of DC-TAB
    Figure Global DC-TAB Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of Etomoxir
    Table Major Players of Etomoxir
    Figure Global Etomoxir Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of IB-MS
    Table Major Players of IB-MS
    Figure Global IB-MS Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of Others
    Table Major Players of Others
    Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) by Type (2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales Share (%) by Type (2013-2018)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Type (2013-2018)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Type in 2017
    Table Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) by Type (2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Revenue Share (%) by Type (2013-2018)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Revenue Share (%) by Type (2013-2018)
    Figure 2017 Global Secondary Progressive Multiple Sclerosis Drug Revenue Market Share (%) by Type
    Table Global Secondary Progressive Multiple Sclerosis Drug Price (USD/Pcs) by Type (2013-2018)
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) by Type (2013-2018)
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales Share (%) by Type (2013-2018)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Type (2013-2018)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Type in 2017
    Table United States Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) by Type (2013-2018)
    Table United States Secondary Progressive Multiple Sclerosis Drug Revenue Share (%) by Type (2013-2018)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Revenue Share (%)by Type (2013-2018)
    Figure 2017 United States Secondary Progressive Multiple Sclerosis Drug Revenue Market Share (%) by Type
    Table United States Secondary Progressive Multiple Sclerosis Drug Price (USD/Pcs) by Type (2013-2018)
    Figure Hospital Examples
    Figure Clinic Examples
    Figure Others Examples
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) Comparison by Application (2013-2025)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) by Application (2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales Share (%) by Application (2013-2018)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Application (2013-2018)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Application in 2017
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) Comparison by Application (2013-2025)
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) by Application (2013-2018)
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales Share (%) by Application (2013-2018)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Application (2013-2018)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Application in 2017
    Table Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
    Figure North America Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Europe Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure South America Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Middle East and Africa Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) by Regions (2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Regions (2013-2018)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Regions (2013-2018)
    Figure 2017 Global Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Regions
    Figure 2017 United States Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) in Global Market
    Table Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) by Regions (2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Revenue Market Share (%) by Regions (2013-2018)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Revenue Market Share (%) by Regions (2013-2018)
    Figure 2017 Global Secondary Progressive Multiple Sclerosis Drug Revenue Market Share (%) by Regions
    Figure 2017 United States Secondary Progressive Multiple Sclerosis Drug Revenue Market Share (%) in Global Market
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table North America Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Europe Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table South America Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Middle East and Africa Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) of Key Players (2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales Share (%) by Players (2013-2018)
    Figure 2017 Global Secondary Progressive Multiple Sclerosis Drug Sales Share (%) by Players
    Figure 2018 Global Secondary Progressive Multiple Sclerosis Drug Sales Share (%) by Players
    Table Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) by Players (2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Revenue Share (%) by Players (2013-2018)
    Table 2017 Global Secondary Progressive Multiple Sclerosis Drug Revenue Share (%) by Players
    Table 2018 Global Secondary Progressive Multiple Sclerosis Drug Revenue Share (%) by Players
    Table Global Market Secondary Progressive Multiple Sclerosis Drug Average Price (USD/Pcs) by Players (2013-2018)
    Table Global Secondary Progressive Multiple Sclerosis Drug Top Players Manufacturing Base Distribution and Sales Area
    Table Global Secondary Progressive Multiple Sclerosis Drug Top Players Product Category
    Figure Global Secondary Progressive Multiple Sclerosis Drug Market Share (%) of Top 3 Players
    Figure Global Secondary Progressive Multiple Sclerosis Drug Market Share (%) of Top 5 Players
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) by Players (2013-2018)
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) by Players (2013-2018)
    Figure 2017 United States Secondary Progressive Multiple Sclerosis Drug Sales Share (%) by Players
    Figure 2018 United States Secondary Progressive Multiple Sclerosis Drug Sales Share (%) by Players
    Table United States Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) by Players (2013-2018)
    Table United States Secondary Progressive Multiple Sclerosis Drug Revenue Market Share (%) by Players (2013-2018)
    Table 2017 United States Secondary Progressive Multiple Sclerosis Drug Revenue Share (%) by Players
    Table 2018 United States Secondary Progressive Multiple Sclerosis Drug Revenue Share (%) by Players
    Table United States Market Secondary Progressive Multiple Sclerosis Drug Average Price (USD/Pcs) by Players (2013-2018)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Market Share (%) of Top 3 Players
    Figure United States Secondary Progressive Multiple Sclerosis Drug Market Share (%) of Top 5 Players
    Table AB Science SA Basic Information List
    Table AB Science SA Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure AB Science SA Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure AB Science SA Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure AB Science SA Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table Actelion Ltd Basic Information List
    Table Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table Biogen, Inc. Basic Information List
    Table Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table F. Hoffmann-La Roche Ltd. Basic Information List
    Table F. Hoffmann-La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table Genzyme Corporation Basic Information List
    Table Genzyme Corporation Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Genzyme Corporation Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure Genzyme Corporation Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure Genzyme Corporation Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table Glialogix, Inc. Basic Information List
    Table Glialogix, Inc. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Glialogix, Inc. Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure Glialogix, Inc. Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure Glialogix, Inc. Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table Immune Response BioPharma, Inc. Basic Information List
    Table Immune Response BioPharma, Inc. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Immune Response BioPharma, Inc. Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure Immune Response BioPharma, Inc. Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure Immune Response BioPharma, Inc. Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table Innate Immunotherapeutics Ltd Basic Information List
    Table Innate Immunotherapeutics Ltd Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Innate Immunotherapeutics Ltd Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure Innate Immunotherapeutics Ltd Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure Innate Immunotherapeutics Ltd Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table Kyorin Pharmaceutical Co., Ltd. Basic Information List
    Table Kyorin Pharmaceutical Co., Ltd. Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Kyorin Pharmaceutical Co., Ltd. Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure Kyorin Pharmaceutical Co., Ltd. Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure Kyorin Pharmaceutical Co., Ltd. Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table Mallinckrodt Plc Basic Information List
    Table Mallinckrodt Plc Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Mallinckrodt Plc Secondary Progressive Multiple Sclerosis Drug Sales Growth Rate (2013-2018)
    Figure Mallinckrodt Plc Secondary Progressive Multiple Sclerosis Drug Sales Global Market Share (%)(2013-2018)
    Figure Mallinckrodt Plc Secondary Progressive Multiple Sclerosis Drug Revenue Global Market Share (%)(2013-2018)
    Table MedDay SA Basic Information List
    Table MedImmune, LLC Basic Information List
    Table Merck KGaA Basic Information List
    Table Meta-IQ ApS Basic Information List
    Table Novartis AG Basic Information List
    Table Opexa Therapeutics, Inc. Basic Information List
    Table Xenetic Biosciences (UK) Limited Basic Information List
    Table Sales Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Secondary Progressive Multiple Sclerosis Drug
    Figure Secondary Progressive Multiple Sclerosis Drug Industrial Chain Analysis
    Table Major Buyers of Secondary Progressive Multiple Sclerosis Drug
    Table Distributors/Traders List
    Figure Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    Figure United States Secondary Progressive Multiple Sclerosis DrugSecondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) Forecast by Regions (2018-2025)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) Forecast by Regions (2018-2025)
    Figure North America Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure North America Secondary Progressive Multiple Sclerosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Europe Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Europe Secondary Progressive Multiple Sclerosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure South America Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure South America Secondary Progressive Multiple Sclerosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Middle East and Africa Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Middle East and Africa Secondary Progressive Multiple Sclerosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (Million USD) Forecast by Type (2018-2025)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) Forecast by Type (2018-2025)
    Table Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Revenue Market Share (%) Forecast by Type (2018-2025)
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales (Million USD) Forecast by Type (2018-2025)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Sales Market Share (%) Forecast by Type (2018-2025)
    Table United States Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) Forecast by Type (2018-2025)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Revenue Market Share (%) Forecast by Type (2018-2025)
    Table Global Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) Forecast by Application (2018-2025)
    Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Forecast by Application (2018-2025)
    Table United States Secondary Progressive Multiple Sclerosis Drug Sales (K Pcs) Forecast by Application (2018-2025)
    Figure United States Secondary Progressive Multiple Sclerosis Drug Sales Forecast by Application (2018-2025)

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@e-marketresearch.com